MOMO syndrome

From WikiMD's WELLNESSPEDIA


MOMO syndrome
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Macrosomia, obesity, macrocephaly, ocular abnormalities
Complications
Onset Congenital
Duration
Types
Causes Genetic mutation
Risks
Diagnosis Clinical diagnosis
Differential diagnosis
Prevention
Treatment Symptomatic treatment
Medication
Prognosis
Frequency Very rare
Deaths


MOMO syndrome is a rare genetic disorder characterized by four primary features: Macrosomia, Obesity, Macrocephaly, and Ocular abnormalities. The syndrome was first described in the medical literature in 1993 by Dr. C. Le Merrer and colleagues. The name MOMO is an acronym derived from the main symptoms of the disorder.

Symptoms and Characteristics[edit]

Individuals with MOMO syndrome typically present with the following features:

  • Macrosomia: This refers to an abnormally large body size and is often noticeable at birth.
  • Obesity: Excessive body fat accumulation, which can develop in early childhood.
  • Macrocephaly: An unusually large head circumference.
  • Ocular abnormalities: These can include a range of eye-related issues, such as strabismus, myopia, and other visual impairments.

Additional features may include developmental delays, intellectual disabilities, and distinctive facial features such as a prominent forehead and a broad nasal bridge.

Genetics[edit]

MOMO syndrome is believed to follow an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in MOMO syndrome have not yet been identified.

Diagnosis[edit]

Diagnosis of MOMO syndrome is primarily based on clinical evaluation and the presence of characteristic symptoms. Genetic testing may be used to support the diagnosis, although the exact genetic cause remains unknown.

Management and Treatment[edit]

There is no cure for MOMO syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary approach, including:

Epidemiology[edit]

MOMO syndrome is extremely rare, with only a few cases reported in the medical literature. Due to its rarity, the exact prevalence is unknown.

See Also[edit]

References[edit]

External Links[edit]

-

This article is a stub related to genetics. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.